Landmark First Human Trial Begins – 100% Telomere Lengthening w/ Dr. Bill Andrews

Dr. Bill Andrews rejoins the program with his college Dr. Jeff Mathis, to discuss the first human telomere trial of it’s kind. The process is currently in pretrial stage and will start with it’s first patient within the next 30 to 60 days. This trial was able to take place due to advances in gene therapy and changes in U.S. legislation over the last 2 years. The focus of the trial will be to treat progressed Alzheimer’s in older patients with no other options. As a by product of the trial, doctors will also be able to observe the results of 100% telomere lengthening on other factors such as aging.

If you or a loved one has progressed Alzheimer’s and you believe you meet the requirements of this trial, please contact Dr. Jeff Mathis at http://libellagt.com

Consider supporting my channel on Patreon and see exclusive additional interviews, ebooks, and research. You can join now at http://Patreon.com/SarahWestall

Follow me on Twitter @ Westall_Sarahw

Stay informed! Sign up for my newsletter

Information shared in the show

Learn more about the TA-65 @ http://Cutt.ly/TA-65
Smart Buying Tip: Remember to select recurring order for much better pricing and discounts (you can always cancel if you change your mind)

Note: TA-65 is the product discovered by Dr. Bill Andrews and was discussed in the video. He discovered this previously and it has been proven to lengthen telomeres. The trial is using a different therapy that has been proven to lengthen telomeres by 100% in the labs. That is a whole different deal.

Learn more about the Hair Growth Serum and help support cancer research: https://cutt.ly/HairGrowthSerum

See episode where scientist Ian Mitchell explains the first round results of the cancer trials: https://youtu.be/aSj0GirWZDY

See episode with scientist Ian Mitchell explain their cancer trials: https://www.youtube.com/watch?v=hPEDJAd2rVA

Dr. Bill Andrews Biography

Dr. Bill Andrews is the president and CEO of Sierra Sciences. He has worked in the biotech industry for 28 years, focusing the last 15 years on finding ways to extend human lifespan through the intervention of telomere shortening in human cells.

See the full Interview on Youtube